




Healthcare Industry News: Vertebral Augmentation System
News Release - November 28, 2011
Ascendx Spine(TM) Appoints Pilar Debelius-Kinsey as Sales and Marketing Manager, Europe
“Our recent European regulatory approvals, combined with the appointment of Pilar to lead our sales and marketing efforts across Europe, position us to gain traction fast in establishing our VCF repair and our VCF augmentation systems, which are designed for the treatment of vertebral compression fractures (VCFs).”Julian M. Mackenzie, CEO
WINTER PARK, Fla.--(Healthcare Sales & Marketing Network)-- Ascendx Spine™ (www.ascendxspine.com), which recently received ISO 13485 Certification and CE marking approval for its Ascendx VCF Repair System and its Acu-Cut Vertebral Augmentation System to treat vertebral compression fractures (VCF), today announced the appointment of Maria Pilar Debelius-Kinsey as Sales and Marketing Manager, Europe, effective immediately.
“Pilar’s significant experience in establishing distributor relationships and sales-and-marketing infrastructures in Europe will spearhead market validation of our Ascendx VCF Repair System and the Acu-Cut Vertebral Augmentation System, which are designed for the treatment of spinal fractures by spine surgeons and interventional radiologists,” said Julian M. Mackenzie, CEO of Ascendx Spine™.
About Ascendx Spine™
Based in Winter Park, Florida, Ascendx Spine™ is a medical device company focused on the development and commercialization of innovative orthopedic devices for the spine and trauma markets. Its initial focus is the Ascendx VCF Repair System for the treatment of a vertebral compression fracture (VCF). A VCF forces a vertebra to collapse and the spinal column above it to assume an abnormal forward curve, resulting in considerable back pain and a hunchbacked appearance.
CAUTION: Neither product—Ascendx VCF Repair System or Acu-Cut Vertebral Augmentation System—is available for sale in the United States.
Source: Ascendx Spine
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.